CommentIs venetoclax the new backbone of acute myeloid leukaemia therapy?
References (8)
- et al.
Venetoclax plus intensive chemotherapy with cladribine, idarubicin, and cytarabine in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a cohort from a single-centre, single-arm, phase 2 trial
Lancet Haematol
(2021) - et al.
Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 study
Blood
(2021) - et al.
Cladribine combined with idarubicin and Ara-C (CLIA) as a frontline and salvage treatment for young patients (≤65 yrs) with acute myeloid leukemia
Blood
(2016) - et al.
Azacitidine and venetoclax in previously untreated acute myeloid leukemia
N Engl J Med
(2020)
There are more references available in the full text version of this article.
Cited by (1)
© 2021 Elsevier Ltd. All rights reserved.